REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 2 filers reported holding REPLIMUNE GROUP INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,483 | -64.1% | 86,700 | -51.3% | 0.00% | -50.0% |
| Q2 2023 | $4,135 | -25.7% | 178,100 | -43.5% | 0.01% | -14.3% |
| Q1 2023 | $5,564 | +6.9% | 315,053 | +64.6% | 0.01% | 0.0% |
| Q4 2022 | $5,205 | -99.8% | 191,353 | +36.7% | 0.01% | +133.3% |
| Q3 2022 | $2,418,000 | -17.1% | 140,000 | -16.1% | 0.00% | 0.0% |
| Q2 2022 | $2,918,000 | -18.6% | 166,953 | -20.9% | 0.00% | -25.0% |
| Q1 2022 | $3,584,000 | +183.5% | 211,053 | +352.4% | 0.00% | +100.0% |
| Q4 2021 | $1,264,000 | +44.3% | 46,653 | +103.1% | 0.00% | +100.0% |
| Q4 2020 | $876,000 | +263.5% | 22,975 | +136.9% | 0.00% | – |
| Q2 2020 | $241,000 | +36.9% | 9,700 | -45.2% | 0.00% | – |
| Q1 2020 | $176,000 | -70.5% | 17,700 | -57.3% | 0.00% | – |
| Q4 2019 | $596,000 | – | 41,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,103,455 | $82,166,000 | 38.87% |
| Bain Capital Life Sciences Investors, LLC | 2,838,968 | $45,707,000 | 10.37% |
| Foresite Capital Management IV, LLC | 1,229,656 | $19,797,000 | 6.49% |
| Foresite Capital Management III, LLC | 779,656 | $12,552,000 | 2.77% |
| BVF INC/IL | 911,852 | $14,681,000 | 1.29% |
| Redmile Group, LLC | 2,192,957 | $35,307,000 | 1.09% |
| Cormorant Asset Management, LP | 467,792 | $7,531,000 | 0.49% |
| DC Investments Management, LLC | 39,578 | $637,000 | 0.43% |
| EMERALD ADVISERS, LLC | 618,080 | $9,951,000 | 0.37% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 523,316 | $8,425,000 | 0.28% |